LAS VEGAS, Dec. 17, 2010 /PRNewswire/ -- Cord Blood America, Inc. (http://www.cordblood-america.com) (OTC Bulletin Board : CBAI ), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today said that Cryo-Cell International has sued Cord Blood America, which CBAI believes is an attempt to inhibit the pending deal between Cryo-Cell Mexico and CBAI.
"Cryo-Cell Mexico is an independent entity. We regard this suit as entirely without merit and simply an attempt to block a legitimate acquisition. We are confident of our position in this matter and will see this through to a favorable conclusion," said Matthew Schissler, Cord Blood America's Chairman, CEO and co-founder.
About Cord Blood America
Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc., visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/.
SOURCE Cord Blood America, Inc.